The Ocular Surface Volume 29, July 2023, Pages 537-546 Stephanie L. Watson, Lyndon W. Jones, Fiona Stapleton, Mark Hinds, Alison Ng, Jacqueline Tan, Yair Alster, Charles Bosworth, Omer Rafaeli, Venita DePuy, The CELESTIAL STUDY Group Over the past few years our own, Mark Hinds, with his team at Ophthalmic Trials Australia (www.ot-au.com) have been involved in the multi-centered investigation into the efficacy and safety of selenium sulfide ointment in the setting of meibomian gland dysfunction (MGD)… Continue reading Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial
Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial
The MiYOSMART spectacle lenses have been found to significantly reduce the progression of myopia and axial elongation in children in the UK, as compared to data from untreated myopes. The study looked at the change in spherical equivalent refraction (SER) and axial length (AL) over a period of 12 months in 87 children between the… Continue reading MiYOSMART Spectacle Lenses for Myopia Control
Myopia, commonly known as nearsightedness, is a growing concern in Australia, especially in children. Myopia occurs when the eye is longer than normal, causing light to focus in front of the retina instead of on it, leading to blurred vision. This can lead to a range of problems, such as difficulty reading or seeing distant… Continue reading Myopia in Australian kids – an easy read
ARVO Abstract Number: 812 – C0495 AuthorBlock: Matilda Biba1, Gareth Lingham1, Emmanuel Kobia-Acquah1, Ian Flitcroft1,2, James Loughman1 1Centre for Eye Research Ireland (CERI), Technological University Dublin, Dublin, Dublin, Ireland; 2Ophthalmology, Children’s Health Ireland at Temple Street, Dublin, Dublin, Ireland; Summary of paper : Myopia, also known as near sightedness, is a condition where a person can see nearby… Continue reading Risk factors for fast and slow myopia progression in a randomized controlled trial of 0.01% atropine eye drops
AZR-MD-001 restores gland gunction and improves signs and ocular symptoms of mebomian gland dysfunction (MGD) Posterboard#: B0072 Abstract Number: 5175 – B0072 AuthorBlock: Preeya Gupta1,2, Laura Elizabeth Downie3, Mark Hinds4, Yair Alster5, Charles Bosworth5 1Ophthalmology, Triangle Eye Consultants, Raleigh, North Carolina, United States; 2Ophthalmology, Tulane University, New Orleans, Louisiana, United States; 3Optometry and Vision Science, The University of Melbourne, Melbourne,… Continue reading The Association for Research in Vision and Ophthalmology (ARVO 2023) Publication
AZR-MD-001 efficacy in resolving the signs and associated symptoms of meibomian gland dysfunction (MGD) in a phase 2 trial: responder status analysis Posterboard#: B0026 Abstract Number: 5129 – B0026 AuthorBlock: Lisa Nijm1,2, Jennifer P. Craig3, Mark Hinds4, Yair Alster5, Charles Bosworth5 1Ophthalmology, Warrenville EyeCare & LASIK, Chicago, Illinois, United States; 2Ophthalmology, University of illinois Eye and Ear Infirmary, Chicago,… Continue reading The Association for Research in Vision and Ophthalmology (ARVO 2023) – Publication.
Atropine Dosage in Australian Population – April 2023 – Myopia Profile Update AbstractTitle: Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: A randomised clinical trialAuthors: Samantha Sze-Yee Lee, Gareth Lingham, Magdalena Blaszkowska, Paul G Sanfilippo, Adrian Koay, Maria Franchina, Audrey Chia, James Loughman, Daniel Ian Flitcroft, Christopher J Hammond, Augusto… Continue reading Atropine Dosage in Australian Population
Our Dry Eye Suite is in full swing! See https://www.markhindsoptometrists.com.au/dry-eye-studio/ E-Eye is a medical device that has been specifically designed for treating dry eye syndrome due to MGD. It generates Intense Regulated Pulsed Light (IRPL) by producing perfectly calibrated and homogeneously sequenced light pulses. The sculpted pulses are delivered under the shape of a train… Continue reading Intense Pulse Light Therapy for Dry Eyes
Mark presented on behalf of SynergEyes USA on hybrid contact lenses. A particular emphasis was on the fitting of UltraHealth hybrid contact lenses for keratoconus patients. Another wonderful conference put on by the Cornea and Contact Lens Society of Australia.
Fitting contact lenses in the setting of presbyopia can be both challenging and rewarding. To optometrists and ophthalmologists from around Australia, Mark presented some insightful ways to optimise success. From the issues of dry eye and ocular surface to contact lens design selection.